[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Gh Research Plc (GHRS)

Gh Research Plc (GHRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,998,580
  • Shares Outstanding, K 68,609
  • Annual Sales, $ 0 K
  • Annual Income, $ -48,260 K
  • EBIT $ -48 M
  • EBITDA $ -60 M
  • 60-Month Beta 1.28
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 5.97

Options Overview Details

View History
  • Implied Volatility 88.61% (+17.61%)
  • Historical Volatility 70.38%
  • IV Percentile 12%
  • IV Rank 9.70%
  • IV High 293.99% on 02/12/26
  • IV Low 66.55% on 04/21/26
  • Expected Move (DTE 35) 2.72 (9.47%)
  • Put/Call Vol Ratio 1.55
  • Today's Volume 51
  • Volume Avg (30-Day) 143
  • Put/Call OI Ratio 0.30
  • Today's Open Interest 1,141
  • Open Int (30-Day) 1,213
  • Expected Range 25.99 to 31.43

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.31
  • Number of Estimates 2
  • High Estimate $-0.29
  • Low Estimate $-0.32
  • Prior Year $-0.15
  • Growth Rate Est. (year over year) -106.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
21.26 +35.06%
on 06/23/26
31.00 -7.39%
on 07/16/26
+7.01 (+32.30%)
since 06/17/26
3-Month
18.38 +56.20%
on 04/23/26
31.00 -7.39%
on 07/16/26
+10.37 (+56.54%)
since 04/17/26
52-Week
11.32 +153.62%
on 08/11/25
31.00 -7.39%
on 07/16/26
+11.46 (+66.43%)
since 07/17/25

Most Recent Stories

More News
Multi-Billion-Dollar Battle for the Future of Depression Treatment Has Begun Creating a Huge Opportunity

EQNX::TICKER_START (NASDAQ:HELP),(NASDAQ:DFTX),(NASDAQ:CMPS),(NASDAQ:GHRS),(NYSE:JNJ) EQNX::TICKER_END

HELP : 7.25 (+2.98%)
CMPS : 12.35 (-0.64%)
GHRS : 28.71 (-1.44%)
JNJ : 253.04 (+1.23%)
DFTX : 44.29 (+0.43%)
Multi-Billion-Dollar Battle for the Future of Depression Treatment Has Begun Creating a Huge Opportunity

NEW YORK, June 30, 2026 (GLOBE NEWSWIRE) -- Market News Updates News Commentary - The way Major Depressive Disorder (MDD) is treated is changing faster than it has in years. For decades, most patients...

HELP : 7.25 (+2.98%)
CMPS : 12.35 (-0.64%)
GHRS : 28.71 (-1.44%)
JNJ : 253.04 (+1.23%)
DFTX : 44.29 (+0.43%)
GH Research's Phase Three Timeline Looks Certain, but the Market Already Moved On

Barchart Research What to Expect from GHRS Earnings GHRS Generated May 13, 2026 Current Price $21.88 EPS Estimate $$-0.27 Consensus Rating Strong Buy Average Move 4.01% GH Research's Phase Three Timeline...

GHRS : 28.71 (-1.44%)
Stocks Finish Higher on Strength in Chip Makers and Energy Producers

The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.64%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +1.23%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.77%. March E-mini S&P...

MSTR : 94.85 (+0.87%)
MPC : 312.60 (+2.21%)
HL : 14.33 (-1.31%)
CDE : 14.35 (-2.97%)
ADI : 375.36 (-1.36%)
GLXY : 21.63 (-3.05%)
JNJ : 253.04 (+1.23%)
SLB : 46.99 (-0.19%)
QXO : 14.40 (-6.61%)
AMGN : 366.29 (-1.42%)
COIN : 157.12 (-2.10%)
PNR : 62.45 (-4.93%)
Chip Makers and Energy Producers Lead Stock Indexes Higher

The S&P 500 Index ($SPX ) (SPY ) today is up +0.72%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +1.32%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.04%. March E-mini S&P futures (ESH26...

MSTR : 94.85 (+0.87%)
MPC : 312.60 (+2.21%)
HL : 14.33 (-1.31%)
CDE : 14.35 (-2.97%)
ADI : 375.36 (-1.36%)
GLXY : 21.63 (-3.05%)
SLB : 46.99 (-0.19%)
QXO : 14.40 (-6.61%)
COIN : 157.12 (-2.10%)
PNR : 62.45 (-4.93%)
AMD : 495.76 (-1.03%)
^BTCUSD : 63,913.82 (-0.28%)
Stocks Climb on AI Spending Optimism and Strength in Energy Producers

The S&P 500 Index ($SPX ) (SPY ) today is up +0.54%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.99%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.78%. March E-mini S&P futures (ESH26...

MSTR : 94.85 (+0.87%)
AMAT : 529.66 (-5.57%)
MPC : 312.60 (+2.21%)
B : 34.93 (+0.26%)
GHRS : 28.71 (-1.44%)
CVX : 187.38 (+1.91%)
HL : 14.33 (-1.31%)
CDE : 14.35 (-2.97%)
ADI : 375.36 (-1.36%)
MBLY : 9.22 (+2.79%)
GLXY : 21.63 (-3.05%)
SLB : 46.99 (-0.19%)
3 Biotech Stocks Wall Street Analysts Predict Will More Than Double

What makes analysts so bullish about these three names from the sector?

MEHCQ : 3.5000 (-2.78%)
GHRS : 28.71 (-1.44%)
TYRA : 32.13 (+1.65%)
DMAC : 7.30 (+2.38%)
XBI : 154.26 (+1.49%)
These 5 Health Care Stocks Saw The Sharpest Retail Interest Jump Last Week

These five small-cap pharma and biotech stocks drew heavy attention on Stocktwits last week, driven by key trial results, FDA updates, and promising drug developments.

MBX : 62.92 (+7.89%)
GHRS : 28.71 (-1.44%)
IVVD : 0.7425 (-5.76%)
RANI : 0.6973 (+4.09%)
LIPO : 0.0327 (-49.38%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

GH Research PLC is a clinical-stage biopharmaceutical company. It dedicated to treat psychiatric and neurological disorders. The company's initial focus is on developing its novel and proprietary 5-MeO-DMT therapies for the treatment of patients with Treatment-Resistant Depression. GH Research PLC is...

See More

Key Turning Points

3rd Resistance Point 33.46
2nd Resistance Point 32.02
1st Resistance Point 30.37
Last Price 28.71
1st Support Level 27.28
2nd Support Level 25.84
3rd Support Level 24.19

See More

52-Week High 31.00
Last Price 28.71
Fibonacci 61.8% 23.48
Fibonacci 50% 21.16
Fibonacci 38.2% 18.84
52-Week Low 11.32

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.